Natalie Wong, MD
Pain Medicine · Sewell, NJNPI 1578812608
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $3,214 of the $5,313 with a category attached, or 60.5%. It is spread thinly across 30 manufacturers, the largest accounting for just 19.4%. Reporting peaked in 2023 at $1,940 and has fallen 59.2% since, to $792 in 2025.
Across 223 payments — averaging $23.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Spinal Simplicity, LLC$1K
- Scilex Pharmaceuticals Inc.$755
- Boston Scientific$682
- Pacira Pharmaceuticals Incorporated$570
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$536
- Amgen$276
- plus $1K from 24 others
What the payments were for
- Travel & lodging$2,09839%
- Food & beverage$3,21461%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Spinal Simplicity, LLC | 4 | $1,031 |
| Scilex Pharmaceuticals Inc. | 63 | $755 |
| Boston Scientific | 6 | $682 |
| Pacira Pharmaceuticals Incorporated | 3 | $570 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 58 | $536 |
| Amgen(2 entities) | 20 | $276 |
| Medtronic(2 entities) | 7 | $271 |
| Collegium Pharmaceutical, Inc. | 11 | $178 |
| Globus Medical | 5 | $143 |
| Si-bone, Inc. | 3 | $109 |
| Redhill Biopharma Inc. | 7 | $95 |
| Vertos Medical, Inc. | 2 | $83 |
| Valinor Pharma, LLC | 4 | $62 |
| Pfizer | 4 | $60 |
| Arbor Pharmaceuticals, Inc. | 4 | $56 |
| Abbott | 2 | $53 |
| IBSA Pharma Inc. | 3 | $43 |
| Avanos Medical | 2 | $36 |
| Azurity Pharmaceuticals, Inc. | 2 | $35 |
| International Rehabilitative Sciences, Inc | 1 | $32 |
| Protega Pharmaceutials Inc | 2 | $29 |
| Almatica Pharma LLC | 2 | $27 |
| Foundation Fusion Solutions, LLC | 1 | $24 |
| Vertex | 1 | $19 |
| Convatec Inc. | 1 | $19 |
| Forte Bio-pharma LLC | 1 | $19 |
| Biotronik NRO, Inc. | 1 | $18 |
| SPR Therapeutics, Inc | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Kowa Pharmaceuticals America, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- HA MINUTEMAN G3-R$970
- SPECTRA WAVEWRITER$647
- Iovera$555
- SYNCHROMED$179
How this compares
$5,313 in reported general payments places this provider in the 80th percentile of 256 pain medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelbucaBuprenorphine Hcl | 31 | $19,176 |
| ZtlidoLidocaine | 20 | $16,400 |
| Diclofenac Sodium | 108 | $13,276 |
| Lidocaine | 86 | $12,065 |
| OxycontinOxycodone Hcl | 32 | $11,385 |
| LyricaPregabalin | 11 | $10,162 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 353 | $9,374 |
| Oxycodone Hcl | 402 | $7,798 |
| Xtampza ErOxycodone Myristate | 15 | $5,475 |
| MovantikNaloxegol Oxalate | 11 | $4,352 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 114 | $2,695 |
| Gabapentin | 262 | $2,685 |
| Buprenorphine | 13 | $2,503 |
| Pregabalin | 116 | $1,783 |
| Celecoxib | 31 | $1,228 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca, Xtampza Er | $178 | $24,65146 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $755 | $16,40020 claims |
| PfizerLyrica | $60 | $10,16211 claims |
| Redhill Biopharma Inc.Movantik | $95 | $4,35211 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 256 pain medicine providers in New Jersey.
Other pain medicine in Sewell
- Burhan HaleemSewell$9K
- Sean LiShrewsbury$1.2M
- Matthias WiederholzLawrenceville$853K
- Todd StitikNewark$370K
- Peter StaatsShrewsbury$286K
- Warren GraceEdison$158K
- Caitlin InnerfieldHaddonfield$97K
- Anson MoiseEnglewood$78K
- Pavli DemianSomerset$65K
- Dipan PatelClifton$50K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.